OCGN
Companies
NASDAQ
Ocugen Inc.
Health Care
$1.09
+$0.28 (+35.40%)
Price Chart
Overview
About OCGN
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Market Cap
$411.8M
Volume
4.7M
Avg. Volume
4.5M
P/E Ratio
-2.2415385
Dividend Yield
0.00%
Employees
90.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.25
Moderate Correlation
Volatility
High (0.79)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, OCGN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$411.8M
Volume4.7M
P/E Ratio-2.24
Dividend Yield0.00%
Important Dates
Next Dividend
September 30, 2019Next Earnings
March 5, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025